A groundbreaking study from Kumamoto University has unveiled a sophisticated genetic mechanism by which the human T-cell leukemia virus type...
A groundbreaking Phase 3 clinical trial, KEYNOTE-426, has delivered compelling evidence that a combination of pembrolizumab and axitinib significantly enhances...
In the intricate world of human genetics, the legacy passed down through our DNA intricately shapes not only visible traits...
In a groundbreaking proteogenomic study, researchers have unveiled the profound impact of missense mutations on protein abundance within prostate cancer...
Researchers at The City College of New York have unveiled groundbreaking insights into the molecular aftermath of chemotherapy, shedding light...
A groundbreaking study from Baylor College of Medicine has unveiled new molecular insights into muscle-invasive bladder cancer (MIBC), a particularly...
Endometrial cancer (EC) commands increasing attention in the field of gynecologic oncology, as it now ranks among the top three...
In a groundbreaking step forward in ovarian cancer research, scientists have unveiled a comprehensive classification tool that deciphers the evolving...
A groundbreaking new study, spearheaded by experts from Weill Cornell Medicine, University Hospitals Cleveland, and Case Western Reserve University, challenges...
In a groundbreaking study published in Blood Advances, researchers have delivered a crucial reevaluation of immunoglobulin replacement therapy in patients...
In a groundbreaking advancement at the intersection of oncology and artificial intelligence, researchers from Southern Medical University in China have...
A groundbreaking study recently published in Nature reveals the promising potential of a single gene therapy injection administered at birth...
In a groundbreaking study published on July 30, 2025, in the prestigious journal Nature, researchers from the University of Colorado...
Liver cancer remains one of the most formidable challenges in oncology, especially for millions affected by fatty liver disease globally....
Hepatocellular carcinoma (HCC), ranking as the third leading cause of cancer-related deaths worldwide, is intimately linked with chronic liver disease,...
Tumor hypoxia, characterized by insufficient oxygen availability within the tumor microenvironment, represents a critical challenge in cancer biology and therapy....
Cancer-associated fibroblasts (CAFs) have long been recognized as pivotal yet perplexing components within the tumor microenvironment, influencing cancer progression and...
A groundbreaking development in mRNA delivery techniques has emerged from researchers at the University of Nevada, Las Vegas (UNLV), promising...
The Hidden Barrier in Cancer Immunotherapy: T-Cell Senescence in the Tumor Microenvironment The intricate battlefield between the immune system and...
In recent years, the rapid advancement of large language models (LLMs) such as ChatGPT and Claude has revolutionized natural language...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.